Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

GSK 1,545.36 -43.87 (-2.76%)
price chart
GlaxoSmithKline 'avoided corporation tax bill of �34m'
LISTENING TO THE FINANCIAL CROWDTop themes and market voices: GlaxoSmithKline Plc. 1.Expansion. 2.Layoffs. 3.Drug Approval Process.
Top Paying Dividend Stocks By Industry
Companies in certain industries and sectors provide higher dividend yields than companies in other industries and sectors. For example, utilities and basic materials companies often provide attractive dividend yields.
Agency versus in-house: One career, two contrasting worlds
He left the agency world more than a decade ago to become global marketing director at GlaxoSmithKline, the healthcare group, but last year leapt back to the agency side.
Top Female Trial Attorney: King & Spalding's Chilton Varner
She tried cases for GlaxoSmithKline PLC related to its premier antidepressant, Paxil, and defended Purdue Pharma LP from the OxyContin addiction litigation that would likely have bankrupted it.
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
... the Future Market 707.2 Future Market Competition Scenario 708 Hepatitis B Therapeutics - Future Players 728.1 Introduction 728.2 Company Profiles 728.2.1 Bristol-Myers Squibb Company 728.2.2 Gilead Sciences 748.2.3 GlaxoSmithKline Plc 758.2.4 F.
Abbott Laboratories settles Depakote case for $1.6 billion
In November, GlaxoSmithKline PLC said it would pay the U.S. government $3 billion to settle civil and criminal charges for illegal marketing of its diabetes drug Avandia and others.
Pronova Defeats Teva, Par In Lovaza Patent Suit
Law360, Los Angeles (May 29, 2012, 10:06 PM EDT) -- A Delaware federal judge ruled Tuesday that Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Inc. infringed two Pronova Biopharma Norge AS patents when they filed applications to sell a ...
Top Female Trial Attorney: Greenberg Traurig's Lori Cohen
Her next trial is another one for I-Flow in Philadelphia in June, followed by a commercial litigation case for GlaxoSmithKline PLC in the fall, also in Philadelphia. She'll be starting jury selection toward the end of the year for an Eli Lilly & Co ...
Study setback weighs on Phytopharm
Shares in Phytopharm slipped back this week after the drug development group unveiled disappointing results from a pre-clinical study into the effectiveness of its glaucoma treatment.
Should investors switch from bonds to shares?
Corporate bonds currently available include those issued by First Group, BT, Aviva, BP, GlaxoSmithKline, National Grid and Vodafone.